|
Digoxin Clinical Trials
3 actively recruiting trials across 2 locations
Pipeline
Phase 2: 2Phase 4: 1
Top Sponsors
- Yale University1
- H. Lee Moffitt Cancer Center and Research Institute1
- Guillermo Liniado1
Indications
- Fatty Liver Disease, Nonalcoholic1
- Acute Heart Failure (AHF)1
- Liver Disease1
- MASH With Fibrosis1
- MASH1
Other1 trial
Birmingham, Alabama1 trial
Digoxin Medulloblastoma Study
University of Alabama at Birmingham Children's of Alabama
Phase 2
New Haven, Connecticut1 trial
Digoxin In NASH (CODIN)
Yale New Haven Health
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.